One of the many challenges of having an autoimmune disease is the mental health struggles that often accompany the physical symptoms.

Many researchers spend years studying the biology of diseases without ever meeting a patient whose life is impacted by the disease or their research.

One of the most common conditions in our registry, Sjogren's disease is notorious for its lengthy diagnosis, with estimated averages of 3-5 years.

Last year, a study was published on CAR-T's success in the treating 5 lupus patients. This year, a new study reported success in adapting CAR-T therapy to treat patients with myasthenia gravis.

As of January 2023, an estimated 11% of Americans continue to experience post-COVID symptoms such as joint pain and brain fog, which are common autoimmune symptoms.

A new study has been published examining the incidence of autoimmune diseases in the UK from 2000 to 2019.

On April 12, the Director of the Office of Research on Women’s Health announced the creation of the NIH Office of Autoimmune Disease Research.

Autoimmune thyroiditis, also known as Hashimoto’s disease, is the most common autoimmune disease in our registry.

In honor of Lupus Awareness Month, we will look at new studies published in the field of lupus research.

Patients with autoimmune diseases are familiar with the impact on our neurological system and brain, leading to symptoms like brain fog, neuropathy, and tremors.

If it seems like we hear more about people being diagnosed with autoimmune diseases these days, it's because they are.

One of the most common symptoms reported by patients with any autoimmune disease is fatigue, which is reported by many as the "most debilitating symptom."

While the presence of T-cell activating proteins doesn't necessarily mean Parkinson's is autoimmune, a recent meta-study has revealed an increased risk for Parkinson's among certain autoimmune diseases.

Those with autoimmune diseases may be especially vulnerable against COVID-19, with some more likely to develop long Covid than the average population.

One of the Autoimmune Registry's goals has always been to support research by connecting patients to clinical trials. New treatments and therapies require . . .

With more than 100 confirmed and suspected autoimmune diseases that collectively affect over 24 million people (just in the US), let’s make sure our diseases do not remain invisible.

In 2020, as COVID-19 spread around the world, more and more patients realized their symptoms didn’t go away. Brain fog, fatigue, and shortness of breath . . .

Another study has just been published that has identified a receptor in our gut lining that can "reprogram the gut microbiome to promote harmful, chronic inflammation."

Autoimmune diseases are often thought of as rare even though, collectively, they affect over 23 million people (just in the US).

Many autoimmune disease patients experience chronic fatigue. Yet this aspect of the disease is often overlooked by physicians . . .